Despite improvements in primary care prevention and treatment, stroke is a devastating disease in the 21st century. Worldwide, stroke affects between 14 and 15 million people each year, meaning that 1 person out of 6 will suffer from a stroke in their lifetime. Stroke is a leading cause of long-term disability and the second leading cause of death , with one death every 6 seconds worldwide.

For stroke patients, every minute counts, leading to the well-known motto “Time is brain”. There are two types of strokes: ischemic stroke caused by blood clot and hemorrhagic stroke caused by an Intracranial hemorrhage (bleeding).

Fast Detection & Interpretation​

Thanks to our triage tools, we enable fast detection of disease and thus a more efficient management.

Reduce Error Rate & Misdiagnosis

By addressing radiologist data overload, stress, and fatigue, we help reduce medical errors and misinterpreted cases.

Improve Quality of Care and Patient Outcome​

Facilitate decision making, ensure a prompt therapeutic response and ultimately improve patient outcome.


Intracranial hemorrhages (ICH) affect over 2 million of persons worldwide with a 40-50% one-month patient mortality and 80% disability despite aggressive care. Therefore, a tool for a quick and accurate early diagnosis of intracranial hemorrhages may facilitate prompt therapeutic response, allow fast decision-making and ultimately improve outcomes

CINA-ICH uses deep learning to identify suspected intracranial hemorrhages and prioritizes those cases in the worklist. It drastically reduces turnaround time for head trauma and stroke patients. Our solution helps radiologists to quickly and accurately identify intracranial hemorrhage in order to facilitate decision making, ensure a prompt therapeutic response and ultimately improve patient outcomes. 


There are 2 types of acute ischemic strokes: small vessel occlusion (SVO) and large vessel occlusion (LVO). Ischemic stroke due to a large vessel occlusion (LVO) accounts for around 80% of all strokes. For every 10 minutes delay, a patient will have a poorer disability outcome. Early diagnosis of LVO is critically important to realize the benefits of patient treatment. 

CINA-LVO is a triage tool for neurovascular emergencies, designed to help physicians improve patient management. The Avicenna’s application provides rapid and automatic large vessel occlusion detection, real-time triage and prioritization. CINA-LVO leverages deep learning to accelerate clinical workflow and helps stroke teams in their diagnosis  improving patient outcome and decreasing the overall cost of care. 


Alberta Stroke Program Early Computed Tomography Score – ASPECTS is a topographic scoring system that divides the brain territory that is affected by the stroke into 10 areas of interest. The obtained score represents the ischemic changes for one of the two hemispheres . 

CINA-ASPECTS, an AI-based automatic tool, offers the possibility of faster, more consistent and more precise interpretation for the assessment of acute ischemic stroke. Beyond providing the ASPECT Score for both sides of the brain, CINA-ASPECTS provides:

  • Heat map indicating the probability of hypodensity and/or sulcal effacement in the brain
  • Outlines and displays the infarcted regions
  • Summary chart with mean Hounsfield Unit per region

CINA, medical images analysis software, is a medical device manufactured Avicenna.AI. This medical device is reserved for health professionals. This software has been designed and manufactured according to the EN ISO 13485 Quality management system. Read the instructions in the notice carefully before any use.

Instructions for Use are available on

Manufacturer: Avicenna.AI (France). 

Medical devices Class I following European Medical Device Directive 93/42/CEE.

Medical devices Class II following the Code of Federal Regulations of the United States of America 21CFR on Medical Devices.

Let's partner together!

Avicenna.AI has built technologies that change how AI is used.
Partner with us to improve radiologists’ capabilities together.
Join Our Newsletter